Home - Medical Policies - Alabama
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing Management
- Hemophilia Drug Management
- Medical Policies
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy Management (RTM)
- Self-Administered Drug Policies
- Transgender Services
Draft Genetic Testing Policies
Effective January 1, 2021, Blue Cross and Blue Shield of Alabama will partner with AIM Specialty Health®, an independent company, to administer genetic testing solutions for our customers.
AIM is our business associate and is an independent company that provides diagnostic testing, information and services. AIM has agreed to follow Blue Cross' privacy and security policies regarding the confidentiality and protection of your personal health information.
Genetic Testing
There are currently no policies on draft. See Current Genetic Testing Policies.
Node: bclrgrpappp1001.corp.bcbsal.org:8080